Funding | pharmaphorum

Skip to main content

Tuesday 26 November 2024

twitter linkedin facebook rss

User account menu

Subscribe

Channels

Content type

Categories

Categories

Sort by

Order

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

close

Channels

Content type

Categories

Categories

Sort by

Order

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

Sign up

twitter linkedin facebook rss

Sign in

Funding

News

Corridor before the hospital morgue

NHS funding crisis affecting community services - report

Financial pressures on the health service are affecting community services, such as testing for sexually transmitted diseases and district nursing, according to a new report by The King’s F

Views & Analysis

A healthy discussion on funding tomorrow’s treatments

A healthy discussion on funding tomorrow’s treatments

The adage 'do more with less' is of increasing relevance to global economies, with governments under pressure to cut and compress public spend yet simultaneously increase both productivity and

News

Bed in a modern clinic corridor

Breaking point is now 'the norm' for NHS, warn doctors

BMA makes stark warning as councils warn social care is also underfunded.

News

RobertFrancisQC

Another NHS hospital safety lapse 'inevitable' warns Francis

Care standards could be compromised in underfunded NHS, warns QC.

News

theresamay

Prime minister accused of being "in denial" about NHS crisis

PM under fire over A&E waiting times.

News

Pharma-patient-technology

Digital health funding breaks records

Total investment reaches $7.9 billion.

Load more results

Editor's Picks

Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn News

Neuralink gets okay for its first international trial

Trump picks celebrity doc Mehmet Oz to lead Medicare

Pfizer elevates Chris Boshoff to top R&D role

Syndax gets FDA okay for first-in-class leukaemia drug

News

Truqap

Relief for AZ as Truqap hits the spot in prostate cancer

After a disappointing result with Truqap in triple-negative breast cancer, AstraZeneca chalks up a win in prostate cancer

Sales & Marketing

Happy lady reading from tablet

Coming soon: The Life Sciences Industry Report 2025 – insigh...

Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Subscribe

rss facebook linkedin twitter

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company